Adherence to Cied Implantation Guidelines and Cardiac Rehabilitation
NCT ID: NCT05764109
Last Updated: 2025-01-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
488 participants
OBSERVATIONAL
2019-09-15
2025-01-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Objective of the present observational study is the evaluation of the adherence to the scientific guidelines in patients with a time-dependent indication to ICD/CRT-D implantation admitted to an in-hospital cardiac rehabilitation program.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
SCREENING FOR THE IMPLANTATION OF A SUBCUTANEOUS IMPLANTABLE AUTOMATIC DEFIBRILLATOR
NCT04101253
Patient-Reported Quality of Life in Patients With an Implantable-Cardioverter Defibrillator - A Longitudinal Observational Study
NCT06654284
Prevention Of Sudden Cardiac Death After Myocardial Infarction by Defibrillator Implantation
NCT05665608
A Randomised Trial of S-ICD Implantation With and Without Defibrillation Testing
NCT03495297
Clinical and Device Functional Assessment of Real World ICD Patients
NCT02341768
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Several factors may justify the differences in ICD implantation rates across Europe and the gap between daily clinical practice and guidelines: economic restrictions, poor guidelines awareness, especially among referring cardiologists and general practitioners, and different guidelines adherence. The impact of "time-dependence" of some indications to CIED implantation on the guidelines adherence is still unknown.
Objective of the present observational study will be the evaluation of the adherence to the scientific guidelines in patients with a time-dependent indication to ICD/CRT-D implantation admitted to an in-hospital cardiac rehabilitation program.
This is a prospective, multicenter, observational study performed in 6 cardiac rehabilitation facilities.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Provision of signed and dated informed consent form;
* Age ≥ 18 years.
* NYHA II-III class at the admittance in the cardiac rehabilitation facility;
* LVEF ≤ 40% at echocardiography at the admittance in the cardiac rehabilitation facility;
* Presence of a time-dependent indication to an ICD/CRT-D implantation:
* \<3 month of optimal medical therapy;
* \<40 days from the index myocardial infarction in patients with acute coronary syndrome;
* 3 months from the revascularization procedure in patients with surgery;
* \<3 months in patients with a de-novo heart failure episode of no ischemic etiology.
* Patients who have already received an ICD/CRT-D for primary prevention before the admittance in the cardiac rehabilitation facility, despite a time-dependent indication to an ICD/CRT-D implantation;
* Indication to ICD-CRT-D implantation for primary prevention.
Exclusion Criteria
* Age \< 18 years;
* NYHA Class I or IV during the cardiac rehabilitation in-hospital stay;
* LVEF \> 40% at echocardiography performed at the admittance in the cardiac rehabilitation facility
* Absence of a time-dependent indication to an ICD/CRT-D implantation;
* Indication to ICD-CRT-D implantation for secondary prevention.
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Istituti Clinici Scientifici Maugeri SpA
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
ICS Maugeri
Pavia, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CE 2296
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.